1. Laboratories Oversight Board 29th January 2019
Programme Performance Update – Reporting Period 12/12/18 to 22/01/19

2. Regular Update Items Key Highlights Programme Budget Programme Metrics
Key Risks & Issues
Stakeholder
Engagement
Key Milestones
Change Control
Requests
Project Updates

3. Blueprint Development Engagement & Communications
Key Highlights
IT Connectivity
NLIIP
Start up meeting complete for NHS Ayrshire and Arran
Initial test list agreed with NHS Ayrshire and Arran
NHS Borders technical issues resolved and pipe cleaning continuing
Dashboard development complete for proof of concept
Demo provided to East region
Engagement sessions with 7 Boards on future development of NLIIP as well as proof of concept
Notable Highlights
Blueprint Development
Engagement & Communications
Date secured for North region workshop and draft programme complete
Meeting of Blueprint Subgroup with proposed approach for standardisation
Review of TB options business case
Website under development
Programme newsletter
Content for website received from North Region

4. Key Programme Metrics @ 22nd January 2019
Stakeholder Engagement
Programme Budget
Programme Resources
Overall Programme Status
Benefits Realisation
Programme Schedule
Programme Leadership

5. Programme Metrics Commentary
Explanatory Commentary
Stakeholder engagement (G)
Stakeholder engagement continuing through the regional groups, networks, IG leads and eHealth leads. Local stakeholder events taken place in North region and being planned in the East region.
Programme Budget (R)
The current year end forecast position indicates an underspend of approximately £320k due to further delay in slower mobilisation than anticipated and additional delays in NPEx deployments. Conversations are ongoing regarding the ability to bid for the carry forward of underdspend monies into 19/20. The programme metric tolerance position of >5% places this metric at red.
Programme Resources (A)
Core programme team currently have a vacancy for a Programme Director. Plans are underway to advertise the post asap.
Benefits Realisation (G)
Committed business case benefits are to be realised from year 2 (19/20) onwards. Current activity focuses on the development of a benefits methodology and approach for presentation to the LOB in March.
Programme Schedule (A)
Programme plan remains at amber with pressure on timescales for NPEx deployments specifically obtaining information governance approvals along with technical issues in NHS Borders and NHS Forth Valley creating delays. A revised schedule including a delay for NHS Orkney and the omission of NHS Western Isles resulting in a change control request.
Programme Leadership (A)
Chief Executive now chairing the North Region Labs Group . Labs Programme Director vacancy places this metric at amber.
Overall Programme (A)
Overall, subjective, metric stays at amber consistent with last performance report. This is due to NPEx deployment change control requests, underspend on budget and pressures coming through on other key milestones. Positive progress made in achievement of proof of concept for NLIIP.

6. Change Control Requests & Decisions
22nd January 2019
2 Changes to NPEx deployment schedule
No business cases received from DSG

7. Stakeholder Engagement & Communications
F2F engagement
Social media channels being explored
Newsletter circulations
Laboratory staff engagement sessions planned with East Region
Programme website has gone live
Regional Boards, Local Board IG and eHealth Leads,

8. Risks, Issues & Dependencies
Summary
Risks
Issues
Red 3
Amber 7 1
Green 2
Issues
IG sign off on data sharing agreement for NHS Orkney and NHS Shetland and NHS Ayrshire and Arran
National roadmap milestone not achievable for March LOB
Technical issue in NHS Borders has halted progress and completion delayed by 2 weeks
Rescheduling of NHS Orkney deployment
Rescheduling of NHS Forth Valley

11. Project Status Updates
IT Connectivity Delivery Project 1
National Laboratories Intelligence & Information Platform Delivery Project 2
Blueprint Development & Benefits Workstream 3

12. IT Connectivity Project
This Period
Last Period
Amber
Red
Start up meeting with NHS Ayrshire and Arran
Agreed initial test list with NHS Ayrshire and Arran
Resolved technical connectivity issues at NHS Borders and resumed pipe clean testing
Agreed deployment approach for NHS Orkney and Shetland
Delivered this period
IG sign off NHS Ayrshire and Arran, NHS Orkney and NHS Shetland
Rescheduling of NHS Forth Valley deployment
Numerous technical connectivity issues at NHS Borders, 2 weeks delay on completion
Technical connectivity issues with NHS Forth Valley
Challenges
Actions for next period
Completion of Organisational Readiness for NHS Shetland and NHS Ayrshire and Arran
Completion of NPEx deployment in NHS Borders
Scope requirements for expansion plans for NHS Dumfries and Galloway and NHS Fife QFIT deployments

13. National Laboratories Intelligence & Information Platform Project
This Period
Last Period
Green
National Laboratories Intelligence & Information Platform Project
Prototype dashboard now live with NHS Fife and Lothian data
Dashboard access to East region users for review and feedback
Engagement sessions with 7 Boards
Demo of dashboard to NLIIP Steering Group
Delivered this period
Managing expectations of end users
Maintaining momentum into Q4
Challenges
Profile NHS Borders data and add to dashboard
Focus groups with West region
Engagement sessions with remaining Boards
Create new programme plan based on outcome of discussions with LOB on way forward
Learning session with SNBTS and SCI store
Actions for next period

14. Blueprint Development & Benefits Workstream
This Period
Last Period
Amber
Green
Blueprint Development & Benefits Workstream
Meeting of Blueprint Subgroup
Review of first Business Case coming via DSG for review
Delivered this period
Communicating the Blueprint more widely with Laboratories stakeholders
Maintaining momentum and ensuring that the Blueprint is actively used as key guiding tool
Maintaining momentum in North and West regions
Challenges
Actions for next period
Highlight areas of commonality and synergy
Identify regional and national building blocks and enablers
North region workshop delivered with priority outputs
Benefits realisation methodology and approach to be presented to the LOB

15. Next LABORATORIES Oversight Board – 14 March
2019
Next LABORATORIES Oversight Board – 14 March

16. Key Programme Metrics Definitions
Stakeholder Engagement
Programme Budget
Programme Resources
Subjective evaluation of whether key stakeholders are active engaged regionally and nationally. This measure is not designed to assess stakeholders agreement on all matters but rather the extent to which they are being actively engaged.
Factual evaluation of actual expenditure variance against the allocated transformation fund monies. Measurement is based on;
<3% variance YTD against control total (G)
<5% variance YTD against control total (A)
>5% variance YTD against forecast (R)
Assessment of whether sufficient resources are place across the central programme team and in the Regions to deliver the key milestones planned within the reporting period being reviewed.
Benefits Realisation
Programme Schedule
Programme Leadership
This metric evaluates the extent to which the benefits outlined in the business case are being realised over each reporting period.
Also considers the underpinning methodology, measurement and tracking approach and local ownership.
Evaluation of delivery achievement against baselined milestone deliverables and events in a particular reporting period. Deliverables are weighted as 20% for milestones and 10% for events, marginal late delivery that does not impact the critical path. Measurement is on;
<10% variance YTD against baseline (G)
<20% variance YTD against baseline (A)
>20% variance YTD against baseline (R)
Baseline plan presented to LOB on 5/11/18.
Assessment of the extent to which senior roles are filled and active sponsorship is evident across the NLPT, LOB and Regions (e.g. Prog Dir, SRO, Chair, CEO, Clinical and Planning Leads). This metric is evaluated based on posts filled but also visible, auditable evidence of active leadership and oversight to drive activities forward, resolve issues and engage stakeholders.